Rosuvastatin Calcium Tablet
Product Images NDC 71335-3172

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 71335-3172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713353172)

Label for Rosuvastatin Tablets, USP 5 mg oral tablets. The package contains 30 tablets and is labeled Rx only. The repackager is Bryant Ranch Prepack, Inc., Burbank, CA, and the manufacturer is Umedica Laboratories Pvt. Ltd. Storage instructions include maintaining temperature between 20° to 25°C and protection from moisture.*

FDA Label Image

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)

A cumulative incidence plot depicting event rates over 6 years comparing Rosuvastatin (solid line) and Placebo (dotted line). The y-axis shows cumulative incidence percentage, and the x-axis shows time in years. A table below shows the number of subjects at risk over time for both groups. Hazard ratio and significance values are noted.*

FDA Label Image

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)

A data table comparing the number of cardiovascular-related events between Rosuva 20 mg and Placebo 20 mg groups in a study of 8,901 patients each. It includes endpoints such as primary end point, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization, with associated hazard ratios, 95% confidence intervals, and p-values. A hazard ratio plot illustrates relative risk reductions across these endpoints.*

FDA Label Image

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)

Box plot graph comparing percent change from baseline in LDL-C levels across varying doses of four statins: Crestor, Atorvastatin, Simvastatin, and Pravastatin. The x-axis shows each drug with doses in milligrams, while the y-axis quantifies percent change, ranging from 0 to -75 percent. Data illustrates dose-dependent LDL-C reduction for each statin.*

FDA Label Image

Logo (Rosuvastatin Tablets Logo)

FDA Label Image

Logo1 (Rosuvastatin Tablets Logo2)

FDA Label Image

Structural_formula (Rosuvastatin Tablets Structure)

Chemical structure of rosuvastatin calcium, showing the molecular arrangement including a fluorophenyl group, sulfonamide, hydroxyl groups, ketone, and calcium ion association.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.